The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9482-9489

  Pallier, Coralie ^a   Greco, Anna ^b   Le Junter, Janine ^a   Saib, Ali ^a   Vassias, Isabelle ^a   Morinet, Frederic ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURST FORMING UNIT; ERYTHROCYTE APLASIA; HEMOLYTIC ANEMIA; MEGAKARYOCYTE; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RIBOSOME; RNA ANALYSIS; RNA TRANSLATION; STEM CELL; VIRUS REPLICATION;

EID: 0030782379     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9482-9489.1997     Document Type: Article

References (46)

1. Beard, C., J. St. Amand, and C. R. Astell. 1989. Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors. Virology 172:659-664.
2. Blundell, M. C., C. Beard, and C. R. Astell. 1987. In vitro identification of a B19 parvovirus promoter. Virology 157:534-538.
3. Brown, K. E., J. R. Hibbs, G. Gallinella, S. M. Anderson, E. D. Lehman, P. McCarthy, and N. S. Young. 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330:1192-1196.
4. Cotmore, S. F., V. C. McKie, L. J. Anderson, C. R. Astell, and P. Tattersall. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol. 60:548-557.
5. Decker, C. J., and R. Parker. 1994. Mechanisms of mRNA degradation in eukaryotes. Trends Biochem. Sci. 19:336-340.
6. Diaz, J. J., D. Simonin, T. Masse, P. Deviller, K. Kindbeiter, L. Denoroy, and J. J. Madjar. 1993. The herpes simplex virus type 1 US11 gene product is a phosphorylated protein found to be non-specifically associated with both ribosomal subunits. J. Gen. Virol. 74:397-406.
7. Doerig, C., B. Hirt, J.-P. Antonietti, and P. Beard. 1990. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol. 64:387-396.
8. Fourney, R. M., J. Miyakoshi, R. S. Day, and M. C. Paterson. 1988 Northern blotting: efficient RNA staining and transfer. Focus 10:5-7.
9. Furth, P. A., and C. C. Baker. 1991. An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65:5806-5812.
10. Giron, M.-L., F. Rozain, M.-C. Debons-Guillemin, M. Canivet, J. Peries, and R. Emanoil-Ravier. 1993. Human foamy virus polypeptides: identification of env and bel gene products. J. Virol. 67:3596-3600.
11. Greco, A., D. Simonin, J. J. Diaz, L. Barjhoux, K. Kindbeiter, J. J. Madjar, and T. Masse. 1994. The DNA sequence coding for the 5′ untranslated region of herpes simplex virus type 1 ICP22 mRNA mediates a high level of gene expression. J. Gen. Virol. 75:1693-1702.
12. Hentze, M. W. 1995. Translational regulation: versatile mechanisms for metabolic and developmental control. Curr. Opin. Cell Biol. 7:393-398.
13. Kozak, M. 1991. Structural features in eucaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:19867-19870.
14. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Leruez-Ville, M., I. Vassias, C. Pallier, A. Cecille, U. Hazan, and F. Morinet. 1997. Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter. J. Gen. Virol. 78:215-219.
16. Liu, J. M., H. Fujii, S. W. Green, N. Komatsu, N. S. Young, and T. Shimada. 1991. Indiscriminate activity from the B19 parvovirus p6 promoter in non-permissive cells. Virology 182:361-364.
17. Liu, J. M., S. W. Green, T. Shimada, and N. S. Young. 1992. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J. Virol. 66:4686-4692.
18. Luo, W., and C. R. Astell. 1993. A novel protein encoded by small RNAs of parvovirus B19. Virology 195:448-455.
19. Momoeda, M., S. Wong, M. Kawase, N. S. Young, and S. Kajigaya. 1994. A putative nucleoside triphosphate-binding domain in the nonstructural pro-tein of B19 parvovirus is required for cytotoxicity. J. Virol. 68:8443-8446.
20. Morey, A. L., J. W. Keeling, H. J. Porter, and K. A. Fleming. 1992. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br. J. Obstet. Gynaecol. 99:566-574.
21. Morinet, F., L. D'Auriol, J. D. Tratschin, and F. Galibert. 1989. Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera. J. Gen. Virol. 70: 3091-3097.
22. Mortimer, P. P., R. K. Humphries, J. G. Moore, R. H. Purcell, and N. S. Young. 1983. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426-429.
23. Muhlrad, D., C. J. Decker, and R. Parker. 1994. Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5′→3′ digestion of the transcript. Genes Dev. 8:855-866.
24. Naeger, L. K., J. Cater, and D. J. Pintel. 1990. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type-specific manner. J. Virol. 64:6166-6175.
25. Ostareck-Lederer, A., D. H. Ostareck, N. Standart, and B. J. Thiele. 1994. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3′ untranslated region. EMBO J. 13:1476-1481.
26. Ozawa, K., J. Ayub, Y. S. Hao, G. Kurtzman, T. Shimada, and N. Young. 1987. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 61:2395-2406.
27. Ozawa, K., J. Ayub, S. Kajigaya, T. Shimada, and N. Young. 1988. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J. Virol. 62:2884-2889.
28. Ozawa, K., J. Ayub, and N. Young. 1988. Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets. J. Biol. Chem. 263:10922-10926.
29. Ozawa, K., G. Kurtzman, and N. Young. 1986. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883-886.
30. Ozawa, K., and N. Young. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 61:2627-2630.
31. Palmer, P., C. Pallier, M. Leruez-Ville, M. Deplanche, and F. Morinet. 1996. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clin. Diagn. Lab. Immunol. 3:236-238.
32. Patzel, V., and G. Sczakiel. 1997. The hepatitis B virus post-transcriptional regulatory element contains a highly stable RNA secondary structure. Biochem. Biophys. Res. Commun. 231:864-867.
33. Pavlakis, G. N., and B. K. Felber. 1990. Regulation of expression of human immunodeficiency virus. New Biol. 2:20-31.
34. Ross, J. 1996. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 12:171-175.
35. Shade, R. O., M. C. Blundell, S. F. Cotmore, P. Tattersall, and C. R. Astell. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J. Virol. 58: 921-936.
36. Shyu, A. B., J. G. Belasco, and M. E. Greenberg. 1991. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:221-231.
37. Snyder, R. O., D.-S. Im, and N. Muzyczka. 1990. Evidence for covalent attachment of the adeno-associated virus (AAV) Rep protein to the ends of the AAV genome. J. Virol. 64:6204-6213.
38. Sol, N., F. Morinet, M. Alizon, and U. Hazan. 1993. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product. J. Gen. Virol. 74:2011-2014.
39. Srivastava, A., E. Bruno, R. Briddell, R. Cooper, C. Srivastava, K. van Besien, and R. Hoffman. 1990. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76:1997-2004.
40. St. Amand, J., and C. R. Astell. 1993. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 192:121-131.
41. Takahashi, T., K. Ozawa, K. Takahashi, S. Asano, and F. Takaku. 1990. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75:603-610.
42. Trempe, J. P., and B. J. Carter. 1988. Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation. J. Virol. 62:68-74.
43. Van Der Vlied, P. 1991. The role of cellular transcription factors in the enhancement of adenovirus DNA replication. Semin. Virol. 2:271-280.
44. Vassias, I., S. Perol, L. Coulombel, M. C. Thebault, P. H. Lagrange, and F. Morinet. 1993. An in situ hybridization technique for the study of B19 human parvovirus replication in bone marrow cell cultures. J. Virol. Methods 44:329-338.
45. Wickens, M., J. Kimble, and S. Strickland. 1996. Monograph 15, p. 411-50. In J. Hershey, M. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
46. Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232-243.